Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Drooger JC, van Tinteren H, de Groot SM, Ten Tije AJ, et al. A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial. Cancer 2016 Jun 17. doi: 10.1002/cncr.30141.
PMID: 27315546

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016